User profiles for Manojeet Bhattacharya
Manojit Bhattacharya. Ph.DAssistant Professor of Zoology, Fakir Mohan University Verified email at sc.fmuniversity.in Cited by 4752 |
Development of epitope‐based peptide vaccine against novel coronavirus 2019 (SARS‐COV‐2): Immunoinformatics approach
Recently, a novel coronavirus (SARS‐COV‐2) emerged which is responsible for the recent
outbreak in Wuhan, China. Genetically, it is closely related to SARS‐CoV and MERS‐CoV. …
outbreak in Wuhan, China. Genetically, it is closely related to SARS‐CoV and MERS‐CoV. …
[HTML][HTML] A detailed overview of SARS-CoV-2 omicron: its sub-variants, mutations and pathophysiology, clinical characteristics, immunological landscape, immune …
The COVID-19 pandemic has created significant concern for everyone. Recent data from
many worldwide reports suggest that most infections are caused by the Omicron variant and its …
many worldwide reports suggest that most infections are caused by the Omicron variant and its …
[HTML][HTML] The drug repurposing for COVID-19 clinical trials provide very effective therapeutic combinations: lessons learned from major clinical studies
SARS-CoV-2 has spread across the globe in no time. In the beginning, people suffered due
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still, …
to the absence of efficacious drugs required to treat severely ill patients. Nevertheless, still, …
Present variants of concern and variants of interest of severe acute respiratory syndrome coronavirus 2: their significant mutations in S‐glycoprotein, infectivity, re …
C Chakraborty, M Bhattacharya… - Reviews in Medical …, 2022 - Wiley Online Library
Newly arising variants of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
are now a threat to global public health and are creating COVID‐19 surges in different …
are now a threat to global public health and are creating COVID‐19 surges in different …
[HTML][HTML] CRISPR-Cas9: a preclinical and clinical perspective for the treatment of human diseases
G Sharma, AR Sharma, M Bhattacharya, SS Lee… - Molecular Therapy, 2021 - cell.com
At present, the idea of genome modification has revolutionized the modern therapeutic research
era. Genome modification studies have traveled a long way from gene modifications in …
era. Genome modification studies have traveled a long way from gene modifications in …
[HTML][HTML] A detailed overview of immune escape, antibody escape, partial vaccine escape of SARS-CoV-2 and their emerging variants with escape mutations
The infective SARS-CoV-2 is more prone to immune escape. Presently, the significant variants
of SARS-CoV-2 are emerging in due course of time with substantial mutations, having the …
of SARS-CoV-2 are emerging in due course of time with substantial mutations, having the …
Probable molecular mechanism of remdesivir for the treatment of COVID-19: need to know more
A Saha, AR Sharma, M Bhattacharya, G Sharma… - Archives of Medical …, 2020 - Elsevier
COVID-19 is now pandemic throughout the world. Scientist, doctors are searching for effective
therapy of this diseases. The remdesivir, an antiviral drug, is appeared as ‘molecule of …
therapy of this diseases. The remdesivir, an antiviral drug, is appeared as ‘molecule of …
[HTML][HTML] From COVID-19 to cancer mRNA vaccines: moving from bench to clinic in the vaccine landscape
Recently, mRNA vaccines have become a significant type of therapeutic and have created
new fields in the biopharmaceutical industry. mRNA vaccines are promising next-generation …
new fields in the biopharmaceutical industry. mRNA vaccines are promising next-generation …
[HTML][HTML] Repurposing drugs, ongoing vaccine, and new therapeutic development initiatives against COVID-19
As the COVID-19 is still growing throughout the globe, a thorough investigation into the
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …
specific immunopathology of SARS-CoV-2, its interaction with the host immune system and …
Advances in nanocarriers enabled brain targeted drug delivery across blood brain barrier
G Sharma, AR Sharma, SS Lee, M Bhattacharya… - International journal of …, 2019 - Elsevier
The blood brain barrier (BBB) offers protection to the central nervous system (CNS) by
maintaining homeostasis. Besides restricting the entry of harmful xenobiotics and endogenous …
maintaining homeostasis. Besides restricting the entry of harmful xenobiotics and endogenous …